Puravankara Limited — Investor Meet, 17-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** In Q3 FY '25, Puravankara reported sales of INR 1,265 Cr, marking a year-on-year increase of 76%. Customer collections rose by 6% to INR 993 Cr for the quarter, with a robust 19% growth year-to-date. Average realization improved by 16% to INR 8,847 per square foot. However, total revenue for the quarter was INR 334 Cr, and the company recorded a net loss of INR 94 Cr, contributing to a comprehensive loss of INR 99 Cr for nine months.

**Future Outlook and Growth Drivers:** Management expressed optimism about sustained growth, citing strong demand across residential and commercial segments, backed by favorable economic policies and increased urbanization. Upcoming launches and a pipeline of approximately 12.63 million square feet signal expansion, particularly in non-Bengaluru markets.

**Order Book and Operational Updates:** The company’s order book remains robust, with significant presales valued at INR 3,724 Cr for nine months. Project launches are expected to accelerate, with major developments in Thane, Mundhwa, and other locations anticipated soon.

**Analyst Q&A Insights:** Analysts sought clarity on revenue and profitability metrics. Management reassured that their strategy included significant upcoming launches and a strong cash surplus to cover debt obligations. JDA (Joint Development Agreement) projects were noted to provide substantial IRR, with expected returns between 20-30%.

**Market or Regulatory Updates:** The sector benefited from a favorable macroeconomic environment, with government policies enhancing buyer sentiment. The reduction in repo rates expectedly positions the firm for improved demand and economic conditions.

**Strategic Focus Areas:** Management emphasized innovation, a strong acquisition focus, and maintaining an effective debt-to-equity ratio. The emphasis on growing market share while optimizing operational efficiency suggests a proactive market positioning.

**Investor Insight:** Given the financial health and strategic focus on growth, along with easing macroeconomic factors, the firm appears poised for continued improvement. The current trajectory supports a favorable outlook, suggesting a “buy” position for investors focused on long-term gains.